Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer

被引:22
作者
Shanmugam, Vijayalakshmi [1 ]
Ramanathan, Ramesh K. [1 ,2 ]
Lavender, Nicole A. [1 ]
Sinari, Shripad [1 ]
Chadha, Manpreet [2 ]
Liang, Winnie S. [1 ]
Kurdoglu, Ahmet [1 ]
Izatt, Tyler [1 ]
Christoforides, Alexis [1 ]
Benson, Hollie [1 ]
Phillips, Lori [1 ]
Baker, Angela [1 ]
Murray, Christopher [1 ]
Hostetter, Galen [3 ]
Von Hoff, Daniel D. [1 ]
Craig, David W. [1 ]
Carpten, John D. [1 ]
机构
[1] Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA
[2] Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[3] VARI, Grand Rapids, MI USA
关键词
Metastatic colorectal cancer; Whole genome sequencing; KRAS mutations; ENDOTHELIAL GROWTH-FACTORS; BCL-2; EXPRESSION; HUMAN BREAST; LUNG-CANCER; MUTATIONS; PATHWAY; GENE; PHOSPHORYLATION; PROLIFERATION; ACTIVATION;
D O I
10.1186/1755-8794-7-36
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The outcome of patients with metastatic colorectal carcinoma (mCRC) following first line therapy is poor, with median survival of less than one year. The purpose of this study was to identify candidate therapeutically targetable somatic events in mCRC patient samples by whole genome sequencing (WGS), so as to obtain targeted treatment strategies for individual patients. Methods: Four patients were recruited, all of whom had received > 2 prior therapy regimens. Percutaneous needle biopsies of metastases were performed with whole blood collection for the extraction of constitutional DNA. One tumor was not included in this study as the quality of tumor tissue was not sufficient for further analysis. WGS was performed using Illumina paired end chemistry on HiSeq2000 sequencing systems, which yielded coverage of greater than 30X for all samples. NGS data were processed and analyzed to detect somatic genomic alterations including point mutations, indels, copy number alterations, translocations and rearrangements. Results: All 3 tumor samples had KRAS mutations, while 2 tumors contained mutations in the APC gene and the PIK3CA gene. Although we did not identify a TCF7L2-VTI1A translocation, we did detect a TCF7L2 mutation in one tumor. Among the other interesting mutated genes was INPPL1, an important gene involved in PI3 kinase signaling. Functional studies demonstrated that inhibition of INPPL1 reduced growth of CRC cells, suggesting that INPPL1 may promote growth in CRC. Conclusions: Our study further supports potential molecularly defined therapeutic contexts that might provide insights into treatment strategies for refractory mCRC. New insights into the role of INPPL1 in colon tumor cell growth have also been identified. Continued development of appropriate targeted agents towards specific events may be warranted to help improve outcomes in CRC.
引用
收藏
页数:13
相关论文
共 53 条
[1]   TGFβ signaling in health and disease [J].
Akhurst, RJ .
NATURE GENETICS, 2004, 36 (08) :790-792
[2]   T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis [J].
Angus-Hill, Melinda L. ;
Elbert, Kathryn M. ;
Hidalgo, Julio ;
Capecchi, Mario R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :4914-4919
[3]   Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion [J].
Bass, Adam J. ;
Lawrence, Michael S. ;
Brace, Lear E. ;
Ramos, Alex H. ;
Drier, Yotam ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Voet, Douglas ;
Saksena, Gordon ;
Sivachenko, Andrey ;
Jing, Rui ;
Parkin, Melissa ;
Pugh, Trevor ;
Verhaak, Roel G. ;
Stransky, Nicolas ;
Boutin, Adam T. ;
Barretina, Jordi ;
Solit, David B. ;
Vakiani, Evi ;
Shao, Wenlin ;
Mishina, Yuji ;
Warmuth, Markus ;
Jimenez, Jose ;
Chiang, Derek Y. ;
Signoretti, Sabina ;
Kaelin, William G., Jr. ;
Spardy, Nicole ;
Hahn, William C. ;
Hoshida, Yujin ;
Ogino, Shuji ;
DePinho, Ronald A. ;
Chin, Lynda ;
Garraway, Levi A. ;
Fuchs, Charles S. ;
Baselga, Jose ;
Tabernero, Josep ;
Gabriel, Stacey ;
Lander, Eric S. ;
Getz, Gad ;
Meyerson, Matthew .
NATURE GENETICS, 2011, 43 (10) :964-U67
[4]   Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study [J].
Burwinkel, Barbara ;
Shanmugam, Kalai S. ;
Hemminki, Kari ;
Meindl, Alfons ;
Schmutzler, Rita K. ;
Sutter, Christian ;
Wappenschmidt, Barbara ;
Kiechle, Marion ;
Bartram, Claus R. ;
Frank, Bernd .
BMC CANCER, 2006, 6 (1)
[5]   Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities [J].
Craig, David W. ;
O'Shaughnessy, Joyce A. ;
Kiefer, Jeffrey A. ;
Aldrich, Jessica ;
Sinari, Shripad ;
Moses, Tracy M. ;
Wong, Shukmei ;
Dinh, Jennifer ;
Christoforides, Alexis ;
Blum, Joanne L. ;
Aitelli, Cristi L. ;
Osborne, Cynthia R. ;
Izatt, Tyler ;
Kurdoglu, Ahmet ;
Baker, Angela ;
Koeman, Julie ;
Barbacioru, Catalin ;
Sakarya, Onur ;
De La Vega, Francisco M. ;
Siddiqui, Asim ;
Hoang, Linh ;
Billings, Paul R. ;
Salhia, Bodour ;
Tolcher, Anthony W. ;
Trent, Jeffrey M. ;
Mousses, Spyro ;
Von Hoff, Daniel ;
Carpten, John D. .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (01) :104-116
[6]   Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047
[7]   Prognostic Significance of the Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Receptors R1, R2, and R3 in Patients With Nonsmall Cell Lung Cancer [J].
de Santa Pau, Enrique Carrillo ;
Carrillo Arias, Fernando ;
Caso Pelaez, Enrique ;
Munoz Molina, Gemma Maria ;
Sanchez Hernandez, Ignacio ;
Muguruza Trueba, Ignacio ;
Balsalobre, Ramon Moreno ;
Sacristan Lopez, Silvia ;
Gomez Pinillos, Alejandro ;
Toledo Lobo, Maria del Val .
CANCER, 2009, 115 (08) :1701-1712
[8]   Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials [J].
Dienstmann, Rodrigo ;
Serpico, Danila ;
Rodon, Jordi ;
Saura, Cristina ;
Macarulla, Teresa ;
Elez, Elena ;
Alsina, Maria ;
Capdevila, Jaume ;
Perez-Garcia, Jose ;
Sanchez-Olle, Gessami ;
Aura, Claudia ;
Prudkin, Ludmila ;
Landolfi, Stefania ;
Hernandez-Losa, Javier ;
Vivancos, Ana ;
Tabernero, Josep .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (09) :2062-2071
[9]   SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer [J].
Fleming, Nicholas I. ;
Jorissen, Robert N. ;
Mouradov, Dmitri ;
Christie, Michael ;
Sakthianandeswaren, Anuratha ;
Palmieri, Michelle ;
Day, Fiona ;
Li, Shan ;
Tsui, Cary ;
Lipton, Lara ;
Desai, Jayesh ;
Jones, Ian T. ;
McLaughlin, Stephen ;
Ward, Robyn L. ;
Hawkins, Nicholas J. ;
Ruszkiewicz, Andrew R. ;
Moore, James ;
Zhu, Hong-Jian ;
Mariadason, John M. ;
Burgess, Antony W. ;
Busam, Dana ;
Zhao, Qi ;
Strausberg, Robert L. ;
Gibbs, Peter ;
Sieber, Oliver M. .
CANCER RESEARCH, 2013, 73 (02) :725-735
[10]   COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer [J].
Forbes, Simon A. ;
Bindal, Nidhi ;
Bamford, Sally ;
Cole, Charlotte ;
Kok, Chai Yin ;
Beare, David ;
Jia, Mingming ;
Shepherd, Rebecca ;
Leung, Kenric ;
Menzies, Andrew ;
Teague, Jon W. ;
Campbell, Peter J. ;
Stratton, Michael R. ;
Futreal, P. Andrew .
NUCLEIC ACIDS RESEARCH, 2011, 39 :D945-D950